191
Views
22
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?

, MD, , , , , & show all
Pages 485-492 | Received 15 Feb 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pekka Collin, Irina Rinta-Kiikka, Sari Räty, Johanna Laukkarinen & Juhani Sand. (2015) Diagnostic workup of liver lesions: Too long time with too many examinations. Scandinavian Journal of Gastroenterology 50:3, pages 355-359.
Read now

Articles from other publishers (21)

Feng Yi Cheo, Celeste Hong Fei Lim, Kai Siang Chan & Vishal Girishchandra Shelat. (2023) The impact of waiting time and delayed treatment on the outcomes of patients with hepatocellular carcinoma: A systematic review and meta-analysis. Annals of Hepato-Biliary-Pancreatic Surgery 28:1, pages 1-13.
Crossref
Nikita Sandeep Wagle, Sulki Park, David Washburn, Robert L. Ohsfeldt, Nicole E. Rich, Amit G. Singal & Hye-Chung Kum. (2023) Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology 21:5, pages 1281-1292.e10.
Crossref
Kittipitch Bannangkoon, Keerati Hongsakul, Teeravut Tubtawee & Phurich Janjindamai. (2023) Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2023, pages 1-9.
Crossref
Aleksandar Filipović, Dragan Mašulović, Marko Živanović, Tamara Filipović, Dušan Bulatović, Miloš Zakošek, Dejan Nikolić & Danijel Galun. (2022) Impact of the COVID-19 Pandemic on the Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: A Single Center Experience from a Developing Country. Medicina 58:12, pages 1701.
Crossref
Jasmina Ehab, Benjamin Powers, Richard Kim, Mintallah Haider, Ovie Utuama, Alicia Chin, Jason Denbo, Bela Kis, Jessica Frakes, Daniel Jeong, Gregory Lauwers, Susan Vadaparampil, Jason B. Fleming & Daniel A. Anaya. (2021) Integrating a Disease-Focused Tumor Board as a Delivery-of-Care Model to Expedite Treatment Initiation for Patients With Liver Malignancies. Annals of Surgical Oncology 29:4, pages 2371-2380.
Crossref
Rajalakshmi Govalan, Michael Luu, Marie Lauzon, Kambiz Kosari, Joseph C. Ahn, Nicole E Rich, Nicholas Nissen, Lewis R. Roberts, Amit G. Singal & Ju Dong Yang. (2021) Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact. Hepatology Communications 6:1, pages 223-236.
Crossref
Yongfei He, Tianyi Liang, Shutian Mo, Zijun Chen, Shuqi Zhao, Xin Zhou, Liping Yan, Xiangkun Wang, Hao Su, Guangzhi Zhu, Chuangye Han & Tao Peng. (2021) Effect of timing of surgical resection of primary hepatocellular carcinoma on survival outcomes in elderly patients and prediction of clinical models. BMC Gastroenterology 21:1.
Crossref
Ashwin RaoNicole E. RichJorge A. Marrero, Adam C. YoppAmit G. Singal. (2021) Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma. Journal of the National Comprehensive Cancer Network 19:9, pages 1063-1071.
Crossref
Diamantis I. Tsilimigras, J. Madison Hyer, Adrian Diaz, Demetrios Moris, Fabio Bagante, Francesca Ratti, Hugo P. Marques, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo & Timothy M. Pawlik. (2020) Impact of time‐to‐surgery on outcomes of patients undergoing curative‐intent liver resection for BCLC‐0, A and B hepatocellular carcinoma. Journal of Surgical Oncology 123:2, pages 381-388.
Crossref
Mengchao Wei, Shuling Chen, Jiali Li, Bin Li, Jingxian Shen, Zhenwei Peng, Qian Zhou, Ying Zou, Xiaofang He, Shaoqiang Li, Dongming Li, Baogang Peng, Jiaming Lai, Sui Peng, Beijiao Qin & Ming Kuang. (2020) Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A. Annals of Surgical Oncology 27:10, pages 3740-3753.
Crossref
Tousif Kabir, Nicholas Syn, M. Ramkumar, Edwin Y.J. Yeo, Jin-Yao Teo, Ye-Xin Koh, Ser-Yee Lee, Peng-Chung Cheow, Pierce K.H. Chow, Alexander Y.F. Chung, London L. Ooi, Chung- Yip Chan & Brian K.P. Goh. (2020) Effect of surgical delay on survival outcomes in patients undergoing curative resection for primary hepatocellular carcinoma: Inverse probability of treatment weighting using propensity scores and propensity score adjustment. Surgery 167:2, pages 417-424.
Crossref
Kerui Xu, Shinobu Watanabe-Galloway, Fedja A. Rochling, Paraskevi A. Farazi, K.M. Monirul Islam, Hongmei Wang & Jiangtao Luo. (2019) Surgical Delay Is Associated with Improved Survival in Hepatocellular Carcinoma: Results of the National Cancer Database. Journal of Gastrointestinal Surgery 23:5, pages 933-943.
Crossref
Wen-Chen Tsai, Pei-Tseng Kung, Yueh-Hsin Wang, Wei-Yin Kuo & Ya-Hsin Li. (2018) Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer. PLOS ONE 13:6, pages e0199532.
Crossref
Charlotte Costentin, Nathalie Ganne-Carrié, Benoit Rousseau, René Gérolami & Jean-Claude Barbare. (2017) Parcours de soins du patient atteint de carcinome hépatocellulaire en France : état des lieux en 2017. Bulletin du Cancer 104:9, pages 752-761.
Crossref
Julie N. Leal, Alexsander K. Bressan, Neeta Vachharajani, Mithat Gonen, Peter T. Kingham, Michael I. D’Angelica, Peter J. Allen, Ronald P. DeMatteo, Majella B.M. Doyle, Oliver F. Bathe, Paul D. Greig, Alice Wei, William C. Chapman, Elijah Dixon & William R. Jarnagin. (2016) Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation. Journal of the American College of Surgeons 222:5, pages 766-779.
Crossref
Morris Sherman, Jordi Bruix, Michael Porayko & Tram Tran. (2012) Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology 56:3, pages 793-796.
Crossref
Alan Spatz & Alexander M.M. Eggermont. (2011) Melanoma — The pieces of the puzzle finally start coming together!. Molecular Oncology 5:2, pages 113-115.
Crossref
Wei‐Ting Chen, Mark Lee Fernandes, Chen‐Chun Lin & Shi‐Ming Lin. (2010) Delay in treatment of early‐stage hepatocellular carcinoma using radiofrequency ablation may impact survival of cirrhotic patients in a surveillance program. Journal of Surgical Oncology 103:2, pages 133-139.
Crossref
Kristopher P. Croome, Robyn Chudzinski & Douglas W. Hanto. (2010) Increasing time delay from presentation until surgical referral for hepatobiliary malignancies. HPB 12:9, pages 644-648.
Crossref
Chao‐Long Chen & Allan M. Concejero. (2009) Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. Journal of Hepato-Biliary-Pancreatic Sciences 17:5, pages 555-558.
Crossref
Tsung‐Ming Chen, Tzu‐Ming Chang, Pi‐Teh Huang, Ming‐Hung Tsai, Lien‐Fu Lin, Chung‐Cheng Liu, Ka‐Sic Ho, Chuan‐Pau Siauw, Po‐Liang Chao & Jai‐Nien Tung. (2008) Management and patient survival in hepatocellular carcinoma: Does the physician's level of experience matter?. Journal of Gastroenterology and Hepatology 23:7pt2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.